No. /Year /Source /Focus //Drugs /Brands /Publication
[1] /1998 /https://www.ncbi.nlm.nih.gov/pubmed/9868897 /TDS //Review
[2] /1998 /http://d-nb.info/951601652/04 /TDS //Book Chapter
[3] /2002 /https://www.ncbi.nlm.nih.gov/pubmed/?term=fauth+wiedersberg+neubert+dittgen /Adhesive backing foil interactions //Alora, Cutanum, Estraderm , Fem7, Menorest, Oesclim
[4] /2006 /https://www.google.es/patents/DE102005015128B4?cl=en /Wafer //Steroid hormones
[5] /2006 /https://www.google.co.in/patents/WO2005058287A3?cl=und Technology without penetration enhancers Hormones, gestodene, estrogen, ethinyl estradiol
[6] /2012 /http://www.ingentaconnect.com/content/govi/pharmaz/2012/00000067/00000006/art00018?crawler=true /Adhesion testing //Testosterone
[7] /2012 /https://www.ncbi.nlm.nih.gov/pubmed/22010861 /Polyurethane technology //Testosterone
[8] /2012 /13 /http://pharmazie-lehrbuch.de/kapitel/4-4.pdf /Methods for testing transdermals //Book Chapter
[9] /2013 /15 /https://www.google.de/patents/US8486443 /UV stable TDS //Hormone, gestodene
[10] /2013 /http://www.keck-marburg.de/Publications /High tolerance TDS //Caffeine
[11] /2013 /http://www.keck-marburg.de/Publications /Polyurethane TDS //Ibuprofen